학술논문
Biomarker analysis from Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients with advanced non-small cell lung cancer (NSCLC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445